Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
JPMORGAN CHASE & CO
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 4,693,888 | -470,269 | 118,802,305,000 | -47,535,695,000 | $25,310.00 |
| 03/31/2023 | Revance Therapeutics, Inc. | RVNC | 5,164,157 | -286,341 | 166,338,000,000 | 166,190,837,000 | $32,210.10 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 5,450,498 | -1,237,427 | 147,163,000 | 54,736,000 | $27.00 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 6,687,925 | -129,280 | 92,427,000 | -40,510,000 | $13.82 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 6,817,205 | -109,201 | 132,937,000 | 19,899,000 | $19.50 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 6,926,406 | 1,844,101 | 113,038,000 | -28,555,000 | $16.32 |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 5,082,305 | 38,734 | 141,593,000 | -7,897,000 | $27.86 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 5,043,571 | 609,745 | 149,490,000 | 25,564,000 | $29.64 |
| 03/31/2021 | Revance Therapeutics, Inc. | RVNC | 4,433,826 | 107,773 | 123,926,000 | 1,326,000 | $27.95 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 4,326,053 | 246,997 | 122,600,000 | 17,729,000 | $28.34 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 4,079,056 | 51,282 | 104,871,000 | 6,513,000 | $25.71 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 4,027,774 | 113,176 | 98,358,000 | 40,422,000 | $24.42 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 3,914,598 | -109,559 | 57,936,000 | -7,375,000 | $14.80 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 4,024,157 | 1,369,385 | 65,311,000 | 30,799,000 | $16.23 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 2,654,772 | 179,869 | 34,512,000 | 3,253,000 | $13.00 |
| 06/30/2019 | Revance Therapeutics, Inc. | RVNC | 2,474,903 | -1,422,967 | 31,259,000 | -30,172,000 | $12.63 |
| 03/31/2019 | Revance Therapeutics, Inc. | RVNC | 3,897,870 | 92,811 | 61,431,000 | -15,165,000 | $15.76 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 3,805,059 | 158,448 | 76,596,000 | -14,021,000 | $20.13 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 3,646,611 | -18,836 | 90,617,000 | -10,000,000 | $24.85 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 3,665,447 | 228,030 | 100,617,000 | -5,255,000 | $27.45 |
| 03/31/2018 | Revance Therapeutics, Inc. | RVNC | 3,437,417 | -120,562 | 105,872,000 | -21,326,000 | $30.80 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 3,557,979 | 11,712 | 127,198,000 | 30,563,000 | $35.75 |
| 12/29/2017 | Revance Therapeutics, Inc. | RVNC | 3,561,679 | 15,412 | 127,330,024 | 30,695,024 | $35.75 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 3,546,267 | -80,336 | 96,635,000 | 892,000 | $27.25 |
| 06/30/2017 | Revance Therapeutics, Inc. | RVNC | 3,626,603 | 166,759 | 95,743,000 | 23,778,000 | $26.40 |
| 03/31/2017 | Revance Therapeutics, Inc. | RVNC | 3,459,844 | 29,686 | 71,965,000 | 961,000 | $20.80 |
| 12/31/2016 | Revance Therapeutics, Inc. | RVNC | 3,430,158 | 162,457 | 71,004,000 | 18,035,000 | $20.70 |
| 09/30/2016 | Revance Therapeutics, Inc. | RVNC | 3,267,701 | 3,267,701 | 52,969,000 | 52,969,000 | $16.21 |
| 06/30/2016 | Revance Therapeutics, Inc. | RVNC | 3,327,022 | 3,327,022 | 45,247,000 | 45,247,000 | $13.60 |
| 03/31/2016 | Revance Therapeutics, Inc. | RVNC | 3,028,574 | 3,028,574 | 52,879,000 | 52,879,000 | $17.46 |
| 03/31/2015 | Revance Therapeutics, Inc. | RVNC | 0 | -722,276 | 0 | -12,236,000 | |
| 12/31/2014 | Revance Therapeutics, Inc. | RVNC | 722,276 | 722,276 | 12,236,000 | 12,236,000 | $16.94 |
| 09/30/2014 | Revance Therapeutics, Inc. | RVNC | 790,817 | 790,817 | 15,287,000 | 15,287,000 | $19.33 |
| 06/30/2014 | Revance Therapeutics, Inc. | RVNC | 675,598 | 675,598 | 22,969,000 | 22,969,000 | $34.00 |
| 03/31/2014 | Revance Therapeutics, Inc. | RVNC | 269,200 | 269,200 | 8,480,000 | 8,480,000 | $31.50 |
| << Prev Next >> |
|